Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2009-07-21 20:27:38 UTC |
---|
Update Date | 2016-11-09 01:08:43 UTC |
---|
Accession Number | CHEM002271 |
---|
Identification |
---|
Common Name | Propiomazine |
---|
Class | Small Molecule |
---|
Description | Propiomazine, an atypical antipsychotic agent, is used to treat both negative and positive symptoms of schizophrenia, acute mania with bipolar disorder, agitation, and psychotic symptoms in dementia. Future uses may include the treatment of obsessive-compulsive disorder and severe behavioral disorders in autism. Structurally and pharmacologically similar to clozapine, propiomazine binds to alpha(1), dopamine, histamine H1, muscarinic, and serotonin type 2 (5-HT2) receptors. |
---|
Contaminant Sources | - HMDB Contaminants - Urine
- T3DB toxins
|
---|
Contaminant Type | - Amine
- Antiemetic
- Drug
- Ester
- Ether
- Histamine Antagonist
- Hypnotic and Sedative
- Metabolite
- Organic Compound
- Synthetic Compound
|
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
10-(2-Dimethylaminopropyl)-2-propionylphenothiazine | ChEBI | 2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine | ChEBI | 3-Propionyl-10-dimethylaminoisopropylphenothiazine | ChEBI | Propiomazina | ChEBI | Propiomazinum | ChEBI | Largon | HMDB |
|
---|
Chemical Formula | C20H24N2OS |
---|
Average Molecular Mass | 340.482 g/mol |
---|
Monoisotopic Mass | 340.161 g/mol |
---|
CAS Registry Number | 362-29-8 |
---|
IUPAC Name | 1-{10-[2-(dimethylamino)propyl]-10H-phenothiazin-2-yl}propan-1-one |
---|
Traditional Name | propiomazine |
---|
SMILES | CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1 |
---|
InChI Identifier | InChI=1S/C20H24N2OS/c1-5-18(23)15-10-11-20-17(12-15)22(13-14(2)21(3)4)16-8-6-7-9-19(16)24-20/h6-12,14H,5,13H2,1-4H3 |
---|
InChI Key | UVOIBTBFPOZKGP-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as phenothiazines. These are polycyclic aromatic compounds containing a phenothiazine moiety, which is a linear tricyclic system that consists of a two benzene rings joined by a para-thiazine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzothiazines |
---|
Sub Class | Phenothiazines |
---|
Direct Parent | Phenothiazines |
---|
Alternative Parents | |
---|
Substituents | - Phenothiazine
- Alkyldiarylamine
- Diarylthioether
- Aryl thioether
- Tertiary aliphatic/aromatic amine
- Aryl alkyl ketone
- Aryl ketone
- Para-thiazine
- Benzenoid
- Ketone
- Tertiary amine
- Tertiary aliphatic amine
- Thioether
- Azacycle
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | |
---|
Biological Roles | |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | 0.454 mg/L |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
GC-MS | GC-MS Spectrum - EI-B (Non-derivatized) | splash10-00di-9100000000-976e369803cbbc61ad7a | Spectrum | GC-MS | GC-MS Spectrum - EI-B (Non-derivatized) | splash10-00di-9100000000-976e369803cbbc61ad7a | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-00fr-9032000000-8ac8d90dc51b6244aecf | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0006-3129000000-8a45d39e43f3fcf55fd4 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-000j-9082000000-53493e52601db97df35b | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0079-9410000000-7fe35b6626b933c91bbb | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000i-0009000000-feea6c99c610382d5059 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-004i-1893000000-516b36aec603eac0bc93 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0pba-9870000000-ff2d57285ef106d3c73f | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0006-0019000000-fe1a7766d0ed20f6cd54 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-000l-9043000000-fb6cfea0a368597116dd | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-000i-9240000000-9f301a72de3beafb7b1f | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000i-0019000000-f17a13bc04340efdfe2f | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-014u-1094000000-7053530da24323a19772 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0fvl-0290000000-cc131874e5924b29218c | Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-00di-9220000000-31dfa9c2a3e2a6046ef7 | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Propiomazine is an antagonist at types 1, 2, and 4 dopamine receptors, serotonin (5-HT) receptor types 2A and 2C, muscarinic receptors 1 through 5, alpha(1)-receptors, and histamine H1-receptors. Its main use as a sedative is due to its antihistamine effect. |
---|
Metabolism | Unknown, but most likely hepatic as with other phenothiazines. |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | Propiomazine is largely used for its antihistamininc sleep inducing effects in treating insomnia. |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | They cause slurred speech, disorientation and "drunken" behavior. They are physically and psychologically addictive. |
---|
Symptoms | Rare, serious side effects include convulsions (seizures); difficult or unusually fast breathing; fast or irregular heartbeat or pulse; fever (high); high or low blood pressure; loss of bladder control; muscle stiffness (severe); unusual increase in sweating; unusually pale skin; and unusual tiredness or weakness. |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB00777 |
---|
HMDB ID | HMDB0014915 |
---|
FooDB ID | Not Available |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Propiomazine |
---|
Chemspider ID | 4771 |
---|
ChEBI ID | 8491 |
---|
PubChem Compound ID | 4940 |
---|
Kegg Compound ID | C07405 |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | Not Available |
---|